Bloomberg Audio Studios, podcasts, radio news, The.
Stock Movers Report, your roundup of companies making moves in the stock market harnessing the power of Bloomberg Data.
Let's take a look at some stocks on the move today. I'm Scarlett Foo here with Paul Sweeney and we're joined by our one and only, Billy Lipshultz. Billy, what do you have?
Yeah, I want to look at one of the worst performers in the SB five hundred, the worst performer in the now that is three M ticker MMM. This came after the industrial company's outlook for the year. I just earnings midpoint below what Wall Street was looking for. JP Morgan calling it mix. One of the things that stood out to me looking through the analyst call and some of the results was kind of the CEO is pitching the maker of post its as reorienting it towards sectors
that are hot, think data centers. Bank of America, though calling out that data center activity only counsel about three percent of their revenue. So as much as you want to lead into nuclear facilities and data centers, things that are all the age not quite working out. So the stockdown right now about seven and a half percent, biggest drop since Friday of tariff Day back in April, So a pretty big move to the downside again, weighing on the Dow. Also weighing on the SP five hundred.
All right, what else do you have for us?
Looking at micro Strategy, I imagine that's one of your favorites, Paul ticker mstr. They are the bitcoin hoarding company. So they announced that they bought more than two billion dollars a bitcoin last week. Michael Saylor kind of continuing to lead into that bet. The interesting thing is seemingly when they buy, they're buying at the highs and then we see the token pull back. So right now bitcoin trading
just north of ninety thousand dollars per token. So when you go out and buy twenty two thousand dollars twenty two thousand bitcoin and then see the price pull back, not really good for you bottom line. So Strategy tickerr MSTR down again more than six call it almost seven percent, biggest drop since earlier this year.
And we're going to talk about this and other crypto issues on Bloomberg Crypto today at twelve pm Eastern time on Bloomberg Television. Stop that you're watching all.
Right, Paul knows I love to talk biotech. So Immunity Biotechnical IPRX right now more than thirty four percent. This is a now seven and a half billion dollar market cap. So this is a drug developer that had a positive meeting with the FDA. We're regarding and an application for a strug treat and bladder cancer. The thing again, that's
interesting for this company. Not only is it up thirty four percent in trading at the highest level since the summer of twenty twenty four, it's hurting short seller shorts betting against the talk about thirty six percent of the share shorted. So whether today is a positive move or really just shorts trying to cover their bets against the company one bright spot in day that's for all intentsive purposes,
been pretty chop it choppy for equity markets. I get another biotech stock moving again, it's either it's binary, thing works stock possible. And this is a stock that had a winning streak to start the year, was trading below two bucks at the end of twenty twenty five, right now north of seven. So if you bought again, took a lotto take it on. An immunity Bio at the end of December working out pretty good.
The Stockmover's Report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.